CRISPR Medicine News

CMN Weekly (15 August 2025) - Your Weekly CRISPR...

Aug. 19, 2025

A plasmid-delivered prime editing strategy corrected the glucose-6-phosphate dehydrogenase (G6PD)...

Breaking: CRISPR screen identifies endosomal...

Aug. 15, 2025

Some of the best links we picked up around the internet

Our pick

CorriXR Therapeutics Secures $1M Investment from...

Jun. 30, 2025

A comprehensive CRISPR-CAS whole-genome screen has revealed key proteins controlling anti-sense oligonucleotide (ASO) activity, with a particular...

Business News

Press Release Service

Aug. 19, 2025

Press Release Service

Gene Editing Market Size, Share, Growth, and...

Aug. 15, 2025

Press Release Service

Promega, Aobious Resolve Patent Infringement...

Broken String Biosciences Renews Commitment to...

Press Release Service

Recent Clinical Trial Updates from CRISPR Medicine...

Aug. 13, 2025

The latest clinical update includes dosing announcements for two trials, with the first patients now...

CMN Weekly (8 August 2025) - Your Weekly CRISPR...

New Partnership Announcement: CMN x EDUGENE

Aug. 8, 2025

Some of the best links we picked up around the internet

CRISPR-Edited Beta Cells Avoid Immune Rejection...

We’re excited to announce a strategic partnership between CRISPR Medicine News (CMN) and EDUGENE -...

CMN Weekly (1 August 2025) - Your Weekly CRISPR...

CRISPR-Cas12b technology was used to edit allogeneic donor islet cells for transplantation into a...

YOLT-203 Awarded EMA Orphan Drug Designation for...

Aug. 1, 2025

Some of the best links we picked up around the internet

Jul. 30, 2025

YolTech Therapeutics announced earlier this week that the European Medicines Agency has granted...

Webinar

PRCSR CRISPR: Vivlion's CRISPR-enabled Discovery...

Nov. 28, 2023

Webinar | Wednesday December 6, 2023 | 3:00 pm–4:30 pm CET / 9:00 am–10:30 am EDT

Webinar

CRISPR Helps Decode the Epigenetic Mysteries of...

Nov. 9, 2023

Webinar | Wednesday November 22, 2023 | 3:00 pm–4:00 pm CET / 9:00 am–10:00 am EDT

CMN Weekly (25 July 2025) - Your Weekly CRISPR...

Extended: CRISPR does not drive resistance in HIV...

Jul. 25, 2025

Some of the best links we picked up around the internet

CMN Weekly (18 July 2025) - Your Weekly CRISPR...

Jul. 22, 2025

Building on prior work demonstrating HIV-1 elimination using dual CRISPR-Cas9 editing and...

Clinical Update: YolTech's Base-Editing Therapy...

Jul. 18, 2025

Some of the best links we picked up around the internet

CMN Weekly (11 July 2025) - Your Weekly CRISPR...

Jul. 16, 2025

YolTech Therapeutics announced on Monday that the Chinese National Medical Products Administration...

CRISPR editors gain precision via evolved hotspots

Jul. 11, 2025

Some of the best links we picked up around the internet

CMN Weekly (4 July 2025) - Your Weekly CRISPR...

Jul. 8, 2025

CRISPR cytosine base editors have been refined through directed evolution of enzyme recognition...

Breaking: CRISPR screen identifies endosomal...

Jul. 4, 2025

Some of the best links we picked up around the internet

CMN Weekly (27 June 2025) - Your Weekly CRISPR...

Jun. 30, 2025

A comprehensive CRISPR-CAS whole-genome screen has revealed key proteins controlling anti-sense...

Tamoxifen controls gene activation with CRISPRa/i

Jun. 27, 2025

Some of the best links we picked up around the internet

Silent mutations alter cell fitness in humans, PE...

Jun. 26, 2025

A tamoxifen-inducible CRISPRa/i system has been developed to enable reversible and rapid control of...

CMN Weekly (20 June 2025) - Your Weekly CRISPR...

Jun. 24, 2025

A high-throughput prime editing screen in human cells reveals that some synonymous mutations, long...

Intellia Reports Positive Three-Year Follow-up...

Jun. 20, 2025

Some of the best links we picked up around the internet

Eli Lilly to Acquire Verve Therapeutics to Advance...

Jun. 18, 2025

Intellia Therapeutics has reported positive three-year follow-data from the ongoing Phase 1/2 trial...

Hydrogel enhances CRISPR-mediated tumour targeting

Jun. 17, 2025

Eli Lilly announced today that it will acquire Verve Therapeutics for up to $1.3 billion to develop...

CMN Weekly (13 June 2025) - Your Weekly CRISPR...

Jun. 16, 2025

Chinese researchers have developed a thermosensitive, polyamine-modified hydrogel that significantly...

First cancer patient dosed in CRISPR-armed phage...

Jun. 13, 2025

Some of the best links we picked up around the internet

Deep learning predicts CRISPR off-target effects

Jun. 12, 2025

SNIPR Biome has dosed the first patient in its Phase 1b trial of SNIPR001, a CRISPR-CAS-armed...

Modalis Partners with SOLVE FSHD to Develop CRISPR...

Jun. 10, 2025

A new computational framework called CCLMoff uses deep learning and RNA language models to predict...

CMN Weekly (6 June 2025) - Your Weekly CRISPR...

Jun. 9, 2025

Modalis Therapeutics has partnered with SOLVE FSHD to advance the development of an experimental...

CRISPR-Cas9 Screens Uncover NR2F2 as a Key...

Jun. 6, 2025

Some of the best links we picked up around the internet

Allogene Therapeutics' ALLO-316 Shows Durable...

Jun. 5, 2025

Using CRISPR-Cas9 screens, researchers in the United States, Belgium and China have identified NR2F2...

Breaking: CRISPR-CAS13 enables programmable RNA...

Jun. 4, 2025

New clinical data from Allogene Therapeutics' Phase 1 TRAVERSE trial reveals durable responses in...

CMN Weekly (30 May 2025) - Your Weekly CRISPR...

Jun. 2, 2025

Today, researchers in researchers in South Korea announced a method to selectively install...

CRISPR-Mediated Removal of Mutated COL7A1 Exons...

May. 30, 2025

Some of the best links we picked up around the internet

Base editors reshape pathogenic repeats

May. 29, 2025

Researchers in Spain and Germany report using CRISPR-mediated exon removal to restore collagen...

CARBON Newsletter (27 May 2025) - Your Latest News...

May. 27, 2025

Researchers have developed a CRISPR-CAS base editing approach to treat trinucleotide repeat...

Carbon

May. 27, 2025

Some of the best links we picked up around the internet

CMN Weekly (23 May 2025) - Your Weekly CRISPR...

Navigating the CAST Landscape: A Review of...

May. 23, 2025

Some of the best links we picked up around the internet

First-Ever Prime-Editing Therapy Shows Safety and...

May. 22, 2025

CRISPR-associated transposons (CASTs) are emerging as powerful tools for genome engineering,...

Novel adenine base editor shows superior precision

May. 21, 2025

Prime Medicine has reported promising initial clinical data from the first-ever trial of a...

Highlight: Tripartite complex boosts non-viral...

May. 20, 2025

Scientists have developed a new adenine base editor (ABE) that matches the efficiency of the widely...

CMN Weekly (16 May 2025) - Your Weekly CRISPR...

May. 19, 2025

Scientists have developed a novel gene editing system that significantly enhances targeted gene...

Breaking: First personalised mRNA CRISPR therapy...

May. 16, 2025

Some of the best links we picked up around the internet

CMN Interview

May. 15, 2025

A team of academic and industry scientists have developed and delivered what may be the world’s...

The Latest Clinical Trial Updates from CRISPR...

Circular ssDNA boosts TALEN editing efficiency

May. 14, 2025

This week's clinical update includes FDA RMAT designation to Beam Therapeutics' BEAM-302 for the...

Gene Editing for Muscular Dystrophies: Where Do We...

May. 13, 2025

Non-viral circular single-stranded DNA improves gene insertion efficiency and cell viability in...

CMN Weekly (9 May 2025) - Your Weekly CRISPR...

May. 12, 2025

Dr. Cecilia Jimenez-Mallebrera, a leading neuromuscular disease researcher, examines how gene...